|
EORTC AISBL / IVZW |
|
|
EORTC AISBL / IVZW |
| Trial Status | Open |
| Dates | Date of activation: 06/05/2008 |
| Data management at EORTC | Full |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: - - All Groups: 950 |
| Number of steps | 2 |
| Drug | IPILIMUMAB |
| Study Staff | Alexander Eggermont (Study Coordinator) - Erasmus University Medical Center, Rotterdam Stefan Suciu (Statistician) - EORTC, Brussels Isabelle Blangenois (Data Manager) - EORTC, Brussels Sven Janssen (Data Manager) - EORTC, Brussels Niels Lema (Data Manager) - EORTC, Brussels Larissa Polders (Data Manager) - EORTC, Brussels Simon Vanderschaeghe (Data Manager) - EORTC, Brussels Jocelyne Flament (Coordinating Physician) - EORTC, Brussels Gaetan de Schaetzen (Project Manager) - EORTC, Brussels, gaetan.deschaetzen( at )eortc.be, +32 2 7741618 |
| Type of cancer | Melanoma |
| Participating Groups | EORTC Melanoma Group(Coordinating Group) BMS 18071 |
| Currently authorized centers | Westmead Hospital (Westmead, Australia) - Inst. 1052 Princess Alexandra Hospital - University Of Queensland (Woolloongabba, Brisbane, Australia) - Inst. 1060 Sir Charles Gairdner Hospital (Nedlands, Australia) - Inst. 1064 Box Hill Hospital (Box Hill, Australia) - Inst. 1072 Greenslopes Private Hospital (Greenslopes, Australia) - Inst. 1078 David Maddison Clinical Sciences (Newcastle, Australia) - Inst. 1094 Cabrini Hospital (Malvern, Australia) - Inst. 9199 Medical University Vienna - General Hospital (Vienna, Austria) - Inst. 906 Medical University of Graz (Graz, Austria) - Inst. 908 Universiteit Gent (Gent, Belgium) - Inst. 104 U.Z. Gasthuisberg (Leuven, Belgium) - Inst. 147 Tom Baker Cancer Centre (Calgary, Canada) - Inst. 1754 Mcgill University - Dept Of Oncology (Montreal, Canada) - Inst. 1765 Cross Cancer Institute (Edmonton - Alberta, Canada) - Inst. 871 General Teaching Hospital In Prague (Prague 2, Czech Republic) - Inst. 961 Research Institute Oncology (Brno, Czech Republic) - Inst. 962 Aarhus University Hospital (Aarhus, Denmark) - Inst. 440 Herlev Hospital - University Copenhagen (Herlev, Denmark) - Inst. 406 Odense University Hospital (Odense, Denmark) - Inst. 411 Helsinki University Central Hospital (Helsinki, Finland) - Inst. 431 Turku University Central Hospital (Turku, Finland) - Inst. 432 Hopital Bichat-Claude Bernard AP-HP (Paris, France) - Inst. 191 Hopital Saint-Louis AP-HP (Paris, France) - Inst. 192 CHU Lyon - Centre Hospitalier Lyon Sud (Pierre-Benite (lyon), France) - Inst. 194 Assistance Publique - Hôpitaux de Marseille - Hopital Sainte-Marguerite (Marseille, France) - Inst. 195 Institut Gustave Roussy (Villejuif, France) - Inst. 225 Centre Alexis Vautrin (Vandoeuvre-Les-Nancy, France) - Inst. 250 C.H.R. De Lille (Lille, France) - Inst. 254 C.H.U. Ambroise Pare AP-HP (Boulogne-Billancourt, France) - Inst. 2303 Eberhard-Karls-Universitaet - Hautklinik (Tuebingen, Germany) - Inst. 3072 Medizinische Universitaet Zu Luebeck (Luebeck, Germany) - Inst. 480 Universitaetsklinikum Koeln (Koeln, Germany) - Inst. 508 Universitaetsklinikum - Essen (Essen, Germany) - Inst. 509 Universitaetsklinikum Schleswig-Holstein (Kiel, Germany) - Inst. 521 UniversitaetsMedizin Mannheim (Mannheim, Germany) - Inst. 527 Georg August Universitaet (Goettingen, Germany) - Inst. 570 Universitaets-Klinik Wuerzburg (Wuerzburg, Germany) - Inst. 576 Universitaetsklinikum Heidelberg (Heidelberg, Germany) - Inst. 578 Charite - Universitaetsmedizin Berlin - Campus Mitte (Berlin, Germany) - Inst. 198 Azienda Ospedaliera Di Padova (Padova, Italy) - Inst. 725 Istituto Regina Elena (Roma, Italy) - Inst. 742 Istituto Nazionale Per La Ricerca Sul Cancro (Genova, Italy) - Inst. 776 Istituto Europeo Di Oncologia (Milano, Italy) - Inst. 3869 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (Napoli, Italy) - Inst. 3870 Universita Degli Studi Di Siena -Policlinico "le Scotte" (Siena, Italy) - Inst. 3922 Norwegian Radium Hospital (Oslo, Norway) - Inst. 841 Maria Sklodowska-Curie Memorial Cancer Centre (Warsaw, Poland) - Inst. 550 Stavropol Clinical Oncology Center - Pyatigorsk (Pyatigorsk, Russia) - Inst. 9270 Ivanovo Regional Oncology Dispensary (Ivanovo, Russia) - Inst. 9271 Tomsk Regional Oncology Dispensary (Tomsk, Russia) - Inst. 9273 Republic Clinical Oncology Dispensary of Ministry of Health of Bashkortostan Republic (Ufa, Russia) - Inst. 9274 City Clinical Oncology Dispensary (Saint-Petersburg, Russia) - Inst. 9275 Republic Clinical Oncology Dispensary of Ministry of Health of Tatarstan Republic (Kazan, Russia) - Inst. 9276 Leningrad Regional Oncology Dispensary (Saint-Petersburg, Russia) - Inst. 9277 Lipetsk Regional Oncology Dispensary (Lipetsk, Russia) - Inst. 9279 Regional Clinical Oncology Dispensary (Krasnodar, Russia) - Inst. 9280 Regional Oncology Dispensary of Minzdrav of Karelia Republic (Petrozavodsk, Russia) - Inst. 9281 S.M. Kirov Military Medical Academy (Saint-Petersburg, Russia) - Inst. 9284 Krasnoyarsk Regional Clinical Oncology Dispensary (Krasnoyarsk, Russia) - Inst. 9290 State Healthcare Institution (Izhevsk, Russia) - Inst. 9291 Itinerary Clinical Hospital on Saratov-2 Station of RZD LLC (Saratov, Russia) - Inst. 9292 Cancer Research Center (Moscow, Russia) - Inst. 6900 Hospital Universitario 12 De Octubre (Madrid, Spain) - Inst. 365 Hospital Clinic Universitari (Barcelona, Spain) - Inst. 369 Karolinska University Hospital, location Solna (Stockholm, Sweden) - Inst. 862 Universitaetsspital (Zurich, Switzerland) - Inst. 453 The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301 Erasmus University Medical Center (Rotterdam, The Netherlands) - Inst. 302 Universitair Medisch Centrum - Academisch Ziekenhuis (Utrecht, The Netherlands) - Inst. 306 Vrije Universiteit Medisch Centrum (Amsterdam, The Netherlands) - Inst. 308 Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310 California Pacific Medical Center (San Francisco, U.S.A.) - Inst. 9095 Siteman Cancer Center (St Louis, U.S.A.) - Inst. 9103 Memorial Sloan-Kettering Cancer Center (New York, U.S.A.) - Inst. 6802 Dana-Farber Cancer Institute & Harvard Medical School (Boston, U.S.A.) - Inst. 6808 Yale University School Of Medicine (New Haven, U.S.A.) - Inst. 6834 Lutheran General Hospital / Advocate Cancer Care Center (Park Ridge, U.S.A.) - Inst. 6863 University Of Utah - Huntsman Cancer Institute (Salt Lake City, U.S.A.) - Inst. 6884 Fred Hutchison Seattle Cancer Care Alliance (Seattle, U.S.A.) - Inst. 8678 H. Lee Moffitt Cancer Center Research Institute (Tampa, U.S.A.) - Inst. 8675 The Angeles Clinic and Research Institute (Los Angeles, U.S.A.) - Inst. 9090 Vanderbilt Ingram Cancer Center (Nashville, U.S.A.) - Inst. 9091 Northern California Melanoma Center (San Francisco, U.S.A.) - Inst. 9092 Melanoma Center Atlantic Health Center (Morristown, U.S.A.) - Inst. 9093 St Luke's Health Hospital & Network (Bethlehem, U.S.A.) - Inst. 9094 Blumenthal Cancer Center (Charlotte, U.S.A.) - Inst. 9156 University of New Mexico, Cancer Care Alliance (Albuquerque, U.S.A.) - Inst. 9163 Beth Israel Deaconess Medical Center (Boston, U.S.A.) - Inst. 9225 Massachussets General Hospital Cancer Center (Boston, U.S.A.) - Inst. 9219 St Georges Hospital (London, United Kingdom) - Inst. 6961 Nottingham City Hospital (Nottingham, United Kingdom) - Inst. 6998 Mid Essex Hospitals - Broomfield Hospital (Broomfield (essex), United Kingdom) - Inst. 7085 St. James'S University Hospital (Leeds, United Kingdom) - Inst. 601 Southampton General Hospital (Southampton, United Kingdom) - Inst. 606 |
| Protocol summary | Link provided by NCI PDQ |
| Protocol documents in PDF (requires password) | 18071.pdf |